About Me
Mark H. Paul is the Executive Director of the Center of Medical Innovation at the University of Utah Health and the leader of the TLO medical device incubator. Prior to this role, Mark served for 16 years as the Global President of the Neurovascular division at Stryker. Stryker Neurovascular is a pioneer and world market leader in the development of technologies for the treatment of Hemorrhagic and Ischemic Stroke. During his tenure, the NV division delivered exceptional global growth as the fastest growing division to over $1.3B in annual revenue. Mark had full P&L responsibilities for all operational functions along with sales and marketing teams across 70 countries. Mark is a +31-year veteran of the Medical Device industry. Over that time, he has led organizations focused on technologies for the less invasive treatment of Neurovascular, Peripheral Vascular and Cardiology, including Peripheral Embolization, Abdominal Aortic Aneurysms and Carotid Intervention. Much of Mark’s career and education has had a global focus, including serving as European Director of Peripheral Vascular based in Paris, France, and VP & GM of International for Boston Scientific Corporation.
Mark started his career with Procter & Gamble, where he spent 5 years in sales and sales management. Mark graduated from the University of Utah, and his education also included time in Selwyn College in Cambridge, England, and the Universite de la Neuchâtel, Switzerland. He has also completed Stryker Executive Business Programs at Harvard and Stanford University Byers Center for Biodesign Executive Program.
Mark currently resides in SLC, Utah. He and his wife, Jana, have 4 children.
